Edmond De Rothschild Holding S.A. Arcellx, Inc. Transaction History
Edmond De Rothschild Holding S.A.
- $6.04 Billion
- Q3 2024
A detailed history of Edmond De Rothschild Holding S.A. transactions in Arcellx, Inc. stock. As of the latest transaction made, Edmond De Rothschild Holding S.A. holds 45,480 shares of ACLX stock, worth $3.07 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
45,480Holding current value
$3.07 Million% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding ACLX
# of Institutions
204Shares Held
44.1MCall Options Held
2.23MPut Options Held
907K-
Paradigm Biocapital Advisors LP New York, NY4MShares$270 Million12.04% of portfolio
-
Perceptive Advisors LLC New York, NY3.89MShares$263 Million8.48% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$253 Million23.89% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$238 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.46MShares$166 Million0.0% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $2.96B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...